MedX Health Corp. announced that Naman Demaghlatrous has been appointed to its Board of Directors. Mr. Demaghlatrous, who was named CEO on March 23, 2022, has over 20 years of healthcare and pharmaceutical industry experience, previously building international market development strategies and distribution networks for Medtronic, Johnson & Johnson, and Atfal Pharma.

He joined MedX in 2021 as Managing Director, Europe, Middle East & Africa Operations, and has since been instrumental in developing and expanding the Company's global market opportunities and establishing distribution partnerships and adoption of MedX's DermSecure® Screening Platform in Europe, the Middle East, and North America. Mr. Demaghlatrous' experience in the international medical technology market has been essential in the design and implementation of a robust business model to capture market share, expand the Company's domestic and international geographic footprints and enter new business verticals.